Currently out of the existing stock ratings of Katie Tryhane, 1 are a BUY (100%).

Katie Tryhane

Work Performance Price Targets & Ratings Chart

Analyst Katie Tryhane works at CREDIT SUISSE

Katie Tryhane’s has documented 2 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRL, Charles River Laboratories at 25-Aug-2022.

Wall Street Analyst Katie Tryhane

Analyst best performing recommendations are on CRL (CHARLES RIVER LABORATORIES).
CRL Charles River Laboratories

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

268

$11.27 (4.39%)

256

14 days ago

6/9 (66.67%)

$22.6 (9.21%)

107

Hold

205

$-51.73 (-20.15%)

220

3 months 19 days ago

11/13 (84.62%)

$33.01 (19.19%)

55

Hold

209

$-47.73 (-18.59%)

212

5 months 4 days ago

2/2 (100%)

$11.43 (5.79%)

85

Buy

275

$18.27 (7.12%)

280

5 months 7 days ago

0/4 (0%)

$75.38 (37.76%)

Hold

235

$-21.73 (-8.46%)

225

6 months 19 days ago

3/3 (100%)

$17.39 (7.99%)

149

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Katie Tryhane?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?